The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Johnson & Johnson is scheduled to release its Q2 earnings results on July 15, 2026, with analysts forecasting earnings of $2.85 per share and $25.05 billion in revenue. The company's stock rose 3.6% ahead of the announcement. Additionally, Zacks reports indicate that JNJ is among the companies poised to beat earnings estimates in their upcoming quarterly reports.